DE

Our products

More than heparin. A European supply solution.

Helaxa combines European sourcing, manufacturing in Germany and full supply-chain traceability to provide a reliable source of heparin for the pharmaceutical industry.

We aim for consistent pharmaceutical quality, reliable supply and competitive value, backed by long-term partnerships and transparent communication.

When you work with us, we provide the best quality products at a competitive price.

 

Pharmaceutical products

Heparin Sodium API

  • Heparin Sodium is a highly purified, unfractionated heparin in the form of the sodium salt. It is a sulphated polysaccharide from the group of glycosaminoglycans, obtained from the mucous membrane of the mammal intestine.
  • Role as active ingredient: Heparin Sodium is a pharmaceutically applicable active ingredient (API) that is produced according to recognized pharmaceutical standards.
  • Average molecular weight range: approx. 12,000–16,000 daltons.
  • Quality standard: Compliant with the applicable pharmacopoeia (Ph. Eur., USP, BP).
  • Application & Helaxa advantage: Anticoagulant for the prophylaxis and treatment of thromboembolic events, as well as for the prevention of blood clotting in medical devices and dialysis systems. This is a critical medicine according to the European Critical Medicines Act and the WHO list of essential drugs. Quality standards are paramount. Having a fully integrated supply chain allows full traceability and control of the entire process, securing the optimal product…

Heparin Crude

  • Heparin Crude (or Crude Heparin) is an unpurified intermediate derived from mammal small intestinal mucosa. It contains heparin in a non-standard form as well as other natural accompanying substances.
  • Role as starting material: Heparin Crude serves as a biological raw material for the industrial production of purified heparin APIs and related glycosaminoglycans. Further processing includes multistage cleaning, standardization and quality control procedures.
  • Average molecular weight range: approx. 5,000–40,000 daltons.
  • Quality standard: In-house specifications.
  • Advantage: Helaxa is back integrated from mucosa to produce in house crude heparin. An efficient supply chain and strong longterm association with European partners allows Helaxa a full tracking and control of the raw materials to secure our crude heparin.

APIs in development

  • Other glycosaminoglycan-based substances with anticoagulative or related pharmacological effects.
  • Depending on the state of development, these substances are classified as research APIs or as biotechnologically produced starting materials. The aim is to optimize efficacy, purity and stability.
  • Average molecular weight range: product-specific variable.
  • Quality standard: In-house specifications.
  • Application: Improvement of thrombosis prophylaxis, development of alternative forms of application and use in innovative biomaterial coatings.

By-products

Industrial fat

Industrial fat is obtained by separation from the heparin extraction process. It consists mainly of neutral lipids and fatty acids with a defined quality profile. The material is processed and standardized for use in industrial applications such as:

  • Oleochemical industry: as raw material for the production of soaps, fatty acids, or biodiesel.
  • Technical applications: as a basis for lubricants and other industrial formulations.
  • Raw material for sustainable green fuel. Its consistent composition and origin from a controlled process make it a reliable raw material stream within the animal by-product valorization chain.

Protein hydrolysates

Protein hydrolysate has a very specific amino acid profile with a high level of free amino acids. This characteristic makes the protein hydrolysate suitable for application as feed, petfood and bio stimulants. Helaxa can offer various concentration grades from liquid to abt. 50% concentrate.

Applications:

  • Feed, aqua-feed & pet food
  • Biostimulant for plants under stress
  • Biogas: feedstock to generate green energy